Apheris
Category: AI in Analytics & BI
Apheris develops a federated computing platform that enables secure data analyses across organizations while keeping proprietary information private. Apheris was founded in 2019. The company is led by Robin Röhm. Based in Berlin, Germany. Team size: 41. Total funding raised: $32.5 million. Latest round: Series A, $20.8M, 2025-01, led by OTB Ventures. Key investors include Octopus Ventures, Heal Capital, LocalGlobe, another.vc.
- Founded
- 2019
- Headquarters
- Berlin, Germany
- Team size
- 41
- Total funding
- $32.5 million
Value proposition
Apheris allows organizations to collaborate on data without moving it, ensuring privacy and compliance while extracting valuable insights.
Products and solutions
Apheris Compute Gateway
Unique value
Apheris' platform allows data to remain in its original location while enabling collaborative analysis, addressing privacy and regulatory concerns.
Target customer
Pharmaceutical companies, research institutions, and large organizations needing secure data collaboration.
Industries served
Pharmaceutical, Biotechnology, Healthcare
Technology advantage
Federated computing and privacy-preserving technologies that allow secure data collaboration without centralization.
How they differentiate
Apheris differentiates itself by focusing on federated learning and privacy-preserving data collaboration, allowing data to remain decentralized.
Main competitors
Owkin, Hazy, Duality Technologies
Key partnerships
AbbVie, Boehringer Ingelheim, Johnson & Johnson, Sanofi
Notable customers
Roche, Johnson & Johnson
Major milestones
Completion of Series A funding Partnerships with major pharmaceutical companies
Growth metrics
Achieved $6.7 million in revenue with a team of 41 employees.
Market positioning
Apheris is positioned as a leader in federated computing for secure data collaboration in the life sciences sector.
Geographic focus
Global, with a strong presence in Europe.
Patents and IP
Not publicly listed
About Robin Röhm
Robin is founder and CEO of apheris AI GmbH, a start-up that develops artificial intelligence algorithms for biomedical data with a focus on privacy preserving technologies. Robin studied medicine, philosophy and mathematics and was professionally trained at UBS in Global Banking.
Official website: https://www.apheris.com/